January 4, 2021
Via EDGAR
| Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Jason Drory | |||||
| Re: | Daré Bioscience, Inc. | ||||
| Registration Statement on Form S-1 (File No. 333-251599) | |||||
Ladies and Gentlemen:
Daré Bioscience, Inc. hereby withdraws its request made earlier today that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced registration statement to 4:00 p.m., Eastern Standard Time, on Tuesday, January 4, 2021, or as soon thereafter as practicable.
| Daré Bioscience, Inc. | |||||
| /s/ Lisa Walters-Hoffert | |||||
| Lisa Walters-Hoffert | |||||
| Chief Financial Officer | |||||